| Vikki Leggettt, MS/CCC-SLP | |
|
22 Fleetwood Pl, Ocean Springs, MS 39564-5112 | |
| (228) 365-6713 | |
| Not Available |
| Full Name | Vikki Leggettt |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 22 Fleetwood Pl, Ocean Springs, Mississippi |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295288934 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | S2917 (Mississippi) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Vikki Leggettt, MS/CCC-SLP 22 Fleetwood Pl, Ocean Springs, MS 39564-5112 Ph: (228) 365-6713 | Vikki Leggettt, MS/CCC-SLP 22 Fleetwood Pl, Ocean Springs, MS 39564-5112 Ph: (228) 365-6713 |
News Archive
GlobalPost's "Global Pulse" blog interviews Mario Raviglione, the director of the WHO's Stop TB Department since 2003, "about the progress and frustrations with detection and treatment of tuberculosis [TB]."
Obesity-related diseases are an increasing health problem. Researchers at the University of Oslo have now uncovered a central component of fat metabolism.
Governor Christie has let down New Jersey's kids and taxpayers with his proposal to eliminate funding for New Jersey's tobacco prevention and cessation program. This proposal will lead to more kids becoming addicted to tobacco, fewer tobacco users getting the help they need to quit, more lives being lost and New Jersey taxpayers paying the bill for higher tobacco-caused health care costs. It is truly penny-wise and pound-foolish budgeting.
Three leading research funders from the UK and North America have joined forces to launch a new global initiative called MEND or, MEchanisms of cellular death in NeuroDegeneration, with a fund of $1.25 million USD (£820,000/$1.56CDN) for targeted research into brain diseases that cause dementia, such as Alzheimer's.
Roche today announced approval of the VENTANA PD-L1 (SP142) Assay by the US Food and Drug Administration as a complementary diagnostic to provide PD-L1 status on patients who are considering treatment with the FDA approved Roche immunotherapy TECENTRIQ™ (atezolizumab) for metastatic urothelial cancer (mUC).
› Verified 2 days ago
Hannah Rosemeyer, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3109 Bienville Blvd, Ocean Springs, MS 39564 Phone: 228-818-1141 Fax: 228-818-1156 | |
Mrs. Anna Walker Sinopoli, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6017 Washington Ave, Ocean Springs, MS 39564 Phone: 228-334-5035 Fax: 844-270-2749 | |
Amy Renae Herbert, CCC, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6017 Washington Ave, Ocean Springs, MS 39564 Phone: 228-697-2269 | |
Chelsea Newman, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8905 Ocean Springs Rd, Ocean Springs, MS 39564 Phone: 228-215-0521 | |
Ms. Denise M Martin, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1260 Ocean Springs Road, The Gardens, Ocean Springs, MS 39564 Phone: 601-206-9195 Fax: 301-957-8391 | |
Anna Reeve, M.S. CCC - SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4 Doctors Dr, Ocean Springs, MS 39564 Phone: 228-818-1207 | |
Ms. Dana Suzanne Mitchell, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6520 Sunscope Dr, Ocean Springs, MS 39564 Phone: 239-216-7727 |